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ABSTRACT Current diagnostic parameters estimating obstructive sleep apnoea (OSA) severity have a
poor connection to the psychomotor vigilance of OSA patients. Thus, we aimed to investigate how the
severity of apnoeas, hypopnoeas and intermittent hypoxaemia is associated with impaired vigilance.
We retrospectively examined type I polysomnography data and corresponding psychomotor vigilance
tasks (PVTs) of 743 consecutive OSA patients (apnoea–hypopnoea index (AHI) ⩾5 events·h−1).
Conventional diagnostic parameters (e.g. AHI and oxygen desaturation index (ODI)) and novel parameters
(e.g. desaturation severity and obstruction severity) incorporating duration of apnoeas and hypopnoeas as
well as depth and duration of desaturations were assessed. Patients were grouped into quartiles based on
PVT outcome variables. The odds of belonging to the worst-performing quartile were assessed. Analyses
were performed for all PVT outcome variables using binomial logistic regression.
A relative 10% increase in median depth of desaturations elevated the odds (ORrange 1.20–1.37, p<0.05)
of prolonged mean and median reaction times as well as increased lapse count. Similarly, an increase in
desaturation severity (ORrange 1.26–1.52, p<0.05) associated with prolonged median reaction time. Female
sex (ORrange 2.21–6.02, p<0.01), Epworth Sleepiness Scale score (ORrange 1.05–1.07, p<0.01) and older age
(ORrange 1.01–1.05, p<0.05) were significant risk factors in all analyses. In contrast, increases in
conventional AHI, ODI and arousal index were not associated with deteriorated PVT performance.
These results show that our novel parameters describing the severity of intermittent hypoxaemia are
significantly associated with increased risk of impaired PVT performance, whereas conventional OSA
severity and sleep fragmentation metrics are not. These results underline the importance of developing the
assessment of OSA severity beyond the AHI.
Copyright ©ERS 2020. This article is open access and distributed under the terms of the Creative Commons Attribution
Non-Commercial Licence 4.0.
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Introduction
Inadequate sleep, due to sleep disorders and shortened sleep times, is widely recognised as a significant
public health burden in Western countries [1]. Good quality sleep is crucial for maintaining
neurocognitive performance [1]. Conversely, an increasing number of occupational accidents and absences,
as well as traffic accidents, are caused by factors decreasing sleep quality [1]. In Australia alone, the
estimated cost of inadequate sleep was USD 45 billion in healthcare and society during 2016–2017 [1].
Obstructive sleep apnoea (OSA) is one of the most prevalent sleep disorders, affecting ⩾20% of the adult
population in Western countries [2–4]. OSA is attributed to daytime symptoms of shortened daytime sleep
latencies as well as chronic fatigue and sleepiness [5–7]. Furthermore, OSA is related to poor
neurocognitive performance and inability to sustain attention [8–10].
Neurocognitive disorders, defined in the Diagnostic and Statistical Manual of Mental Disorders, cover the
domains of learning and memory, language, executive functioning and complex attention, among others [11].
Psychomotor vigilance task (PVT) evaluates the domain of complex attention, by measuring repeated
responses to visual stimuli to assess the subject’s ability to sustain attention [8, 12]. PVT is a fast, objective
and easily interpretable test that has very little learning effect [13]. PVT is considered highly reliable and
sensitive to the effect of sleep deprivation on cognitive performance and demonstrates clearly the
cumulative worsening of performance during the task when an individual is unable to sustain attention
[14]. As clinical resources for objective evaluation of sleepiness are limited and subjective questionnaires
unreliable, PVT could be used, for example, as an initial assessment for the fitness to drive [15], with the
constraint that driving also involves other complex skills in addition to sustained attention.
Studies have found impairments in PVT performance with acute sleep deprivation [16] and chronic sleep
restriction [9], but also high inter-individual differences in responses [17]. Furthermore, the association
between worsening PVT outcomes and the usual clinical parameters that describe the severity of OSA (i.e. the
apnoea–hypopnoea index (AHI)) or degree of sleep fragmentation (i.e. arousal index) is equivocal [9, 18–22].
Previous studies have shown that an increase in AHI is not directly linked to impaired vigilance [9, 22].
Even though patients suffering from severe OSA have on average inferior PVT performance compared to
healthy individuals, no significant differences in PVT performance between OSA severity groups have
been reported [9, 22, 23]. However, this lack of differences in OSA patients could be related to arbitrary,
outdated and suboptimal severity classification thresholds for the AHI [24, 25].
Even though the AHI does not correlate well with reduced PVT performance, PACK et al. [9] reported that
impaired performance in PVT seems to result from long-term sleep deprivation and insufficient sleep
durations in OSA patients. Furthermore, previous studies suggest that the level of nocturnal intermittent
hypoxaemia negatively affects PVT performance in OSA patients [10, 18]. SFORZA et al. [18] showed
that the number of lapses correlated moderately with the minimum and mean blood oxygen saturation
(r=−0.454 and −0.421, respectively), but this was achieved using an atypically long reaction time limit of
1000 ms. In addition, we recently demonstrated that longer and deeper desaturations, regardless of the
AHI, significantly increases the risk of objectively measured excessive daytime sleepiness [7].
Based on this apparent connection between intermittent hypoxaemia and impaired daytime functioning of
OSA patients, we hypothesise that novel, more sophisticated diagnostic parameters that consider the
duration of respiratory events as well as the depth and duration of desaturations have a stronger
association to impaired PVT performance than conventional severity indices such as AHI and oxygen
desaturation index (ODI). In this study, we investigate which OSA severity indices are associated with poor
PVT performance in a large patient cohort. In addition, we examine how the severity of desaturations
affects PVT performance independently of the number and total duration of the respiratory events.
Patients and methods
This was a retrospective analysis of 912 consecutive patients undergoing polysomnography (PSG) in the
Sleep Disorders Center of Princess Alexandra Hospital (Brisbane, Australia) due to the suspicion of OSA.
The institutional human research ethics committee of the Princess Alexandra Hospital approved the
retrospective data collection (HREC/16/QPAH/021, LNR/2019/QMS/54313). Patients who failed to
complete PVTs (n=32), had AHI <5 events·h−1 (n=134) or had missing demographic information (n=3)
were excluded. Thus, the studied patient population consisted of 743 individuals, who had successfully
undergone type 1 diagnostic PSG, had AHI ⩾5 events·h−1 upon PSG and successfully completed the PVT.
The PVT was conducted between 19:00 and 21:00 h prior to the PSG. The demographic information of
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the whole patient population is presented in table 1. PSG recordings were conducted and scored using the
Compumedics Grael acquisition system and Compumedics ProFusion PSG 4 software (Compumedics,
Abbotsford, Australia) during 2015–2017.
All PSG recordings were scored manually by experienced sleep technicians, who regularly participate in
scoring concordance activities. All apnoeas, hypopnoeas and desaturations were scored manually in
conformity with the America Academy of Sleep Medicine 2012 guidelines [26]. A hypopnoea was scored if
a ⩾30% reduction in nasal pressure amplitude was observed for ⩾10 s and was associated with either ⩾3%
desaturation and/or an arousal (recommended hypopnoea rule 4A [26]). An apnoea was scored if a ⩾90%
reduction in amplitude for ⩾10 s in the thermistor signal was observed. An oxygen desaturation event was
manually scored if a ⩾3% drop in oxygen saturation signal (SpO2) measured by pulse oximeter, was
observed. Desaturation events were scored from the last sampling point before the onset of the
desaturation to the point when recovery reached the baseline (figure 1). If the baseline was not reached,
the end-point was determined at the start of plateau after the desaturation (figure 1).
For PVT, the Psychology Experiment Building Language PVT programme on an ASUS transformer pad (Taipei,
Taiwan) with an attached keyboard was used [27]. PVT was performed using the 10-min protocol, with 120
visual stimuli occurring at 2–10-s intervals. Patients were instructed to monitor the tablet display and press a
response button using the index finger or thumb on their dominant hand as soon as the pink stimulus appeared
on the screen. Standard PVT outcomes were recorded: median reaction time (RT), mean reciprocal reaction time
(RRT), mean of the slowest 10% RT, mean of the fastest 10% RT and the number of lapses (RT >500 ms).
Raw SpO2 signals, hypnograms and the information (e.g. duration, start and end points) of scored apnoea,
hypopnoea, arousal and desaturation events were exported from ProFusion to MatLab (version R2018b;
MathWorks, Natick, MA, USA). Total sleep time (TST) and percentages of non-rapid eye movement sleep
and rapid eye movement sleep from TST were based on manual sleep staging results. AHI, oxygen
desaturation index (ODI), arousal index, average nocturnal oxygen saturation (mean SpO2), minimum
nocturnal oxygen saturation (min SpO2), time spent with SpO2 <90% (t90%) and the mean and median
depth of desaturations were computed. In addition, novel parameters (obstruction duration, desaturation
duration, desaturation severity and obstruction severity) (table 2) described in our previous studies [28–30],
were computed based on the respiratory and desaturation event information and raw SpO2 signal with
custom-made MatLab functions. All types of apnoeas (obstructive, mixed, central) were considered in the
analyses and none of the patients had central sleep apnoea, i.e. percentage of central events <50% of all
events. Physiologically irrelevant SpO2 values (⩽50%) within desaturations or in minimum SpO2 were
considered as artefacts and were not used in analyses.
Obstruction duration parameter represents the percentage of the total duration of apnoeas (figure 1 and
table 2) and hypopnoeas (figure 1 and table 2) from TST. Similarly, the desaturation duration parameter
TABLE 1 Demographic, polysomnographic and psychomotor vigilance task (PVT) data of the
studied patient population





Age years 56.8 (46.4–66.7)
BMI kg·m−2 35.1 (30.3–41.3)
TST h 5.0 (4.2–5.9)
NREM % 83.3 (78.3–88.4)
REM % 16.6 (11.6–21.7)
AHI events·h−1 23.7 (12.5–45.0)
ESS score 10 (6–14)
RRT 1/ms 2.6 (2.2–2.9)
Median RT ms 380.0 (340.0–445.0)
Fastest 10% RT ms 297.0 (277.0–335.8)
Slowest 10% RT ms 691.0 (544.3–1081.0)
PVT lapses# n 13 (5–36)
Data are presented as n (%) or median (interquartile range), unless otherwise stated. COPD: chronic
obstructive pulmonary disease; BMI: body mass index; TST: total sleep time; NREM: non-rapid eye
movement sleep; REM: rapid eye movement sleep; AHI: apnoea–hypopnoea index; ESS: Epworth
Sleepiness Scale; RRT: mean reciprocal reaction time; RT: reaction time. #: reaction times >500 ms.
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represents the percentage of the total duration of desaturations (figure 1 and table 2) from TST.
Desaturation severity parameter represents the severity of desaturation events (i.e. desaturation area)
(figure 1 and table 2) normalised by TST. Desaturation areas were computed by using the start and end
time of each individual desaturation event and numerically integrating the corresponding desaturation area
(figure 1). In addition, the obstruction severity parameter is defined as a TST normalised sum of
multiplications between apnoea or hypopnoea duration, and corresponding desaturation area (table 2).
For statistical analyses, patients were grouped into PVT performance quartiles (Q1–Q4) based on each of
the five PVT outcome variables (tables 1 and 3). After grouping, multivariate binomial logistic regression
was used to investigate which parameters were associated with impaired PVT performance. Multivariate
binomial logistic regression was chosen due to the assumption that the connection between OSA severity
indices and poor PVT performance is nonlinear and multivariate, and because the method does not
require any transformations for the PVT outcome variables. The patients belonging to the
worst-performing quartiles were compared to the patients belonging to the best-performing quartiles.
Models were first adjusted for sex, age, body mass index (BMI), Epworth Sleepiness Scale (ESS) score,
smoking status and existing comorbidities (depression, hypertension and COPD). The coexistence of
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FIGURE 1 Schematic representation of the variables related to novel parameters. HypDur: duration of
hypopnoea(s); ApDur: duration of apnoea (s); DesDur: duration of desaturation(s); DesArea: area of a
desaturation(s).
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depression and all the other comorbidities were reported based on medical history or interview in the
sleep clinics. The partial maximum likelihood estimates of β-coefficients for belonging to the
worst-performing PVT quartile were computed individually for every investigated parameter and adjusting
factor. Second, the model was adjusted for TST, AHI, arousal index and obstruction duration to examine
how the severity of desaturations affects PVT performance independently. This additionally adjusted
model was used for two reasons. First, to test the hypoxaemia hypothesis in a more detailed manner by
controlling the number and duration of respiratory events. Second, we wanted to avoid the use of
predefined limits for OSA severity classes, and rather treat AHI as a continuous variable. After computing
the β-coefficients for all models, the coefficients were converted to odds ratios according to the
logit-function. As examined parameters differ substantially in the order of magnitude, their values were
normalised by the maximum value of each parameter in question before the analyses. However, the
normalised 1% increase, e.g. in AHI would have produced an increase of 1.7 events·h−1 and for median
desaturation depth an increase of 0.29%. Thus, the parameter values were further scaled to equal a 10%
relative change to achieve a comparable and clinically more meaningful increase.
Results
Comparison between the worst- and best-performing PVT quartiles
The comparison between Q1 and Q4 was performed individually for every examined OSA severity metric
with two different multivariate logistic regression models. When the model was adjusted for demographics,
subjective sleepiness and comorbidities, an increase in either t90%, desaturation severity parameter, mean
desaturation depth or median desaturation depth significantly elevated the odds of longer median RT (OR
1.17–1.26). Slower RRT (OR 1.24–1.26) (table 4) was significantly associated with an increase in mean and
median desaturation depth. Only an increase in t90% (OR 1.18, p=0.04) and median desaturation depth
(OR 1.20, p=0.02) significantly elevated the odds of having a higher number of lapses. An increase in
desaturation severity parameter (p=0.06) and mean desaturation depth (p=0.09) were at the borderline of
significantly elevating the odds of belonging to Q4 based on lapses. In addition, an increase in the median
desaturation depth showed significantly (OR 1.25, p=0.04) elevated odds of belonging to Q4 based on the
fastest 10% RT.
With the model additionally adjusted for TST, arousal index, AHI and obstruction duration parameter, the
worsening in all examined hypoxaemia parameters significantly elevated the odds of belonging to Q4 based
on the number of lapses; however, a decrease in the mean SpO2 (p=0.10) and increase in mean desaturation
depth (p=0.12) did not significantly affect the odds of having longer median RT compared to other
hypoxaemia parameters (table 4). An increase either in desaturation severity parameter (OR 1.43, p=0.01) or
median desaturation depth (OR 1.36, p=0.02) significantly elevated the odds of belonging to Q4 based on
RRT. In addition, investigation of slowest 10% RT quartiles showed that an increase in obstruction severity
parameter (OR 1.39, p=0.04), t90% (OR 1.19, p=0.04) or median depth (OR 1.27, p=0.02) elevated the odds
of belonging to Q4. None of the parameters were significantly associated with the odds of belonging to Q4
based on the fastest 10% RT. Results of similar analyses comparing Q4 to all other quartiles are presented in
supplementary table S1.
TABLE 3 Demographic and polysomnographic data in the worst-performing psychomotor vigilance task (PVT) quartile (Q4) and
best-performing quartile (Q1) based on each examined PVT outcome
RRT 1/ms Median RT ms Slowest 10% RT ms Fastest 10% RT ms Lapses#
Q1 (>2.9) Q4 (<2.2) Q1 (<340.0) Q4 (>445.0) Q1 (<544.3) Q4 (>1081.0) Q1 (<277.0) Q4 (>335.8) Q1 (<5) Q4 (>36)
Patients (female %) 154 (21.4) 202 (58.4) 189 (22.2) 184 (59.8) 186 (26.8) 186 (50.0) 192 (27.1) 186 (59.7) 189 (25.9) 180 (56.1)
Depression 21 (13.6) 46 (22.8) 25 (13.2) 41 (22.3) 26 (14.0) 40 (21.5) 33 (17.2) 38 (20.4) 26 (13.8) 43 (23.9)
Hypertension 50 (32.5) 92 (45.5) 69 (36.5) 85 (46.2) 69 (37.1) 90 (48.4) 70 (36.5) 86 (46.2) 65 (34.4) 83 (46.1)
Smoker 26 (16.9) 36 (17.8) 33 (17.5) 34 (18.5) 27 (14.5) 36 (19.4) 33 (17.2) 31 (16.7) 31 (16.4) 34 (18.9)
COPD 12 (7.8) 25 (12.4) 14 (7.4) 22 (11.2) 12 (6.5) 24 (12.9) 17 (8.9) 18 (9.7) 14 (7.4) 23 (12.8)
Age years 52.5 (42.8–63.7) 58.4 (48.9–68.1) 54.1 (42.9–65.4) 58.9 (49.9–69.4) 52.5 (42.8–63.7) 58.7 (49.0–69.0) 52.5 (43.0–64.8) 58.4 (50.2–68.1) 51.3 (42.8–62.1) 58.9 (49.4–68.5)
BMI kg·m−2 34.3 (30.1–40.4) 35.0 (30.1–41.9) 34.0 (30.1–40.4) 35.0 (30.1–42.0) 34.9 (30.1–41.8) 35.0 (29.8–40.7) 35.4 (30.1–40.5) 35.4 (30.4–41.6) 33.9 (29.2–40.4) 34.9 (30.2–42.1)
TST h 5.0 (4.0–5.9) 5.0 (4.0–5.9) 5.0 (4.0–5.9) 5.0 (4.0–6.0) 5.1 (4.2–6.0) 5.0 (3.9–5.9) 5.1 (4.0–5.9) 4.9 (4.0–5.8) 5.2 (4.3–5.9) 4.9 (3.9–5.9)
NREM % 82.0 (77.5–87.2) 82.9 (78.3–88.2) 82.0 (77.6–87.6) 82.9 (78.3–88.3) 82.1 (77.4–88.5) 82.6 (78.0–88.2) 82.5 (78.4–88.5) 82.6 (78.3–87.8) 82.1 (77.7–88.2) 82.5 (78.1–88.2)
REM % 18.1 (12.8–22.5) 17.2 (11.8–21.7) 18.0 (12.4–22.4) 17.1 (11.7–21.7) 18.0 (11.5–22.6) 17.4 (11.8–22.0) 17.5 (11.6–21.7) 17.4 (12.2–21.7) 17.9 (11.8–22.3) 17.5 (11.8–21.9)
AHI events·h−1 25.8 (13.0–47.2) 22.2 (11.5–42.1) 27.0 (13.5–45.7) 22.5 (11.8–42.1) 27.5 (13.0–49.4) 21 (11.4–42.3) 24.7 (12.0–43.7) 22.8 (11.5–42.1) 27.5 (12.9–48.7) 22.9 (11.8–46.9)
ESS score 9 (5–13) 11 (6–16) 9 (5–13) 11 (6–16) 9 (5–13) 11 (6–17) 10 (6–14) 11 (5–16) 9 (5–12) 11 (6–17)
Data are presented as n (% of population) or median (interquartile range). RRT: mean reciprocal reaction time; RT: reaction time; BMI: body
mass index; TST: total sleep time; NREM: non-rapid eye movement sleep; REM: rapid eye movement sleep; AHI: apnoea–hypopnoea index;
ESS: Epworth Sleepiness Scale. #: reaction times >500 ms.
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Demographic variables as risk factors for impaired PVT performance
When demographic risk factors, subjective sleepiness (ESS) and risk of comorbidities were assessed, only
female sex, higher ESS score and older age were significantly associated with elevated odds of impaired PVT
performance. Female sex (ORrange 2.21–6.02, p<0.01) and increase in ESS (ORrange 1.05–1.07, p<0.01) were
significant risk factors with all PVT outcome variables, whereas increasing age was significant in all analyses
with quartiles based on RRT, median RT and lapses (ORrange 1.01–1.05, p<0.05). BMI, smoking and
coexistence of depression, COPD or hypertension had no association with impaired PVT performance.
Discussion
In this study, we investigated the role of conventional and novel PSG parameters in predicting PVT
performance in a sample of 743 OSA patients. We found that our novel parameters describing the severity
of intermittent hypoxaemia are significantly associated with increased risk of impaired PVT performance,
whereas conventional OSA severity and sleep fragmentation metrics (i.e. AHI, ODI and arousal index) are
not. This finding is supported by our previous study [7], showing that OSA-related objective daytime
sleepiness is more strongly associated with the severity of individual desaturations than the number of
apnoeas and hypopnoeas. Furthermore, the present results correspond with previous studies [8, 9, 18–22],
by showing that conventional AHI-based assessments of OSA have little connection to poor PVT
performance. These findings highlight, together with recent studies [7, 24, 29, 31], the clinical importance
of a more detailed analysis of PSG recordings when assessing OSA severity, symptoms and daytime
functioning. As the presented novel parameters are based on routine manual scoring of PSG, they can be
easily implemented by clinics without any extra work required of technical or medical staff [32].
Based on our results, the severity of nocturnal intermittent hypoxaemia is the strongest PSG-related
indicator of poor PVT performance. The more severe desaturations leading to longer median reaction
times and a higher number of lapses were consistent within each subgroup analysis (table 4) and
consistent with previous studies [10, 18]. Our results show that larger desaturation areas and deeper
desaturations negatively affect the vigilance and the ability to sustain attention in OSA patients.
Interestingly, the duration of desaturations was not a significant factor in elevating the odds of impaired
TABLE 4 The odds of belonging to the worst-performing psychomotor vigilance task (PVT) quartile (Q4) compared to











Model adjusted for sex, age, BMI, ESS and comorbidities
TST h 1.05 1.07 0.99 1.06 1.02
AHI events·h−1 1.05 1.04 0.91 1.05 0.96
ODI events·h−1 1.07 1.09 0.95 1.07 1.00
Arousal index events·h−1 0.99 0.98 0.93 0.96 0.95
Obstruction duration % 1.04 1.01 0.92 1.05 0.97
Desaturation duration % 1.07 1.09 0.97 1.07 1.02
Desaturation severity % 1.24 1.26 1.04 1.20 1.17
Obstruction severity s% 1.18 1.17 1.07 1.13 1.14
Mean SpO2 % 0.51 0.63 0.69 0.82 0.54
Minimum SpO2 % 0.88 0.94 0.97 0.97 0.94
t90% s 1.14 1.17 1.11 1.08 1.18
Mean# depth % 1.21 1.21 1.07 1.19 1.16
Median¶ depth % 1.26 1.25 1.10 1.25 1.20
Model adjusted for sex, age, BMI, ESS, comorbidities, TST, AHI,
arousal index, and obstruction duration
Desaturation severity % 1.43 1.52 1.33 1.31 1.48
Obstruction severity s% 1.33 1.38 1.39 1.22 1.36
Mean SpO2 % 0.55 0.60 0.54 0.83 0.47
t90% s 1.11 1.16 1.19 1.06 1.23
Mean depth# % 1.27 1.26 1.19 1.21 1.27
Median depth¶ % 1.36 1.34 1.27 1.32 1.37
Quartiles and the corresponding odds are defined separately for each PVT outcome variable. All odds are adjusted for smoking status and
coexistence of hypertension, depression and COPD. Bold type represents statistical significance (p<0.05). RRT: mean reciprocal reaction time;
RT: reaction time; BMI: body mass index; ESS: Epworth Sleepiness Scale; TST: total sleep time; AHI: apnoea–hypopnoea index; ODI: oxygen
desaturation index; SpO2: oxygen saturation; t90%: time spent at <90% oxygenation;
#: mean depth of all desaturations; ¶: median depth of all
desaturations.
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PVT performance (table 4). It has been shown that OSA-related intermittent hypoxaemia causes neuronal
brain damage and similar changes as in ischaemic injury [33]. Furthermore, a recent study shows that
systemic intermittent hypoxaemia readily translates to cerebral hypoxaemia in healthy individuals,
indicating that there are limits to which the autoregulation system can prevent hypoxaemia in the cerebral
vasculature [34]. The combination of our results with these findings suggests that the depth of
desaturations, in conjunction with the repetitive failure of the cerebral autoregulation system, may drive
the cognitive impairment seen in OSA patients.
The highest and most significant odds ratios were induced by desaturation severity parameter, median
desaturation depth and mean desaturation depth across all analyses. Comparisons between the
demographically adjusted and additionally adjusted models (table 4) show that when the number and
duration of the apnoeas and hypopnoeas are invariant, increasing depth and area of desaturations will
elevate the odds of prolonged reaction times. It has been previously shown that patients with similar AHI
values can exhibit highly different responses in peripheral blood oxygenation [29]. These findings suggest
that there exist substantial differences between patients in how rapidly peripheral oxygenation decreases
and how fast reoxygenation to baseline occurs. Therefore, further studies are warranted to consider the
morphology of desaturations, as well as the decrease and recovery rates of SpO2 within desaturation events,
and the association of these factors with cardiovascular outcomes and daytime symptoms in OSA patients.
As we hypothesised, the more detailed diagnostic parameters have a significantly stronger connection to
impaired PVT performance than AHI or other conventional PSG parameters. Against this hypothesis, our
results indicate that the duration of apnoeas, hypopnoeas and desaturations does not seem to affect PVT
performance as much as the depth of desaturations. The obstruction severity parameter is defined as the
multiplications of desaturation areas and durations of the corresponding respiratory event, whereas
desaturation severity is independent of respiratory event duration. Therefore, it is reasonable that the
obstruction severity parameter has less significance than the desaturation severity parameter, as the
duration of the events was found to be insignificant. It is noteworthy that obstruction severity was
developed for home sleep apnoea testing and therefore, no arousal-related hypopnoeas could have been
considered. This is persuasive for the development of PSG-modified obstruction severity parameter, where
severity of arousals could be quantified using, e.g. the frequency content and the duration of arousal in a
similar manner compared to the desaturation area. Based on the results achieved for the detailed
hypoxaemia parameters with both adjustment schemes, it can be speculated that deteriorated vigilance is
much more dependent on physiological consequences caused by apnoeas and hypopnoeas rather than the
number or the duration of events per se. In addition, as the emphasis of this study was to assess the role of
intermittent hypoxaemia in vigilance failure, only a limited number of electroencephalogram (EEG) and
sleep fragmentation metrics were investigated in this study. Therefore, further studies are warranted for
detailed EEG analyses and their connection to the impaired PVT performance to gain more
comprehensive information on the factors causing vigilance deterioration.
This study was based on a relatively large, well-balanced clinical sample of patients whose demographics,
symptoms and comorbidities reflect well general OSA populations (table 1), making the obtained results
generalisable to clinical populations. However, clinical and epidemiological populations can include other
comorbid sleep disorders, such as insomnia and restless legs syndrome among others, which may have a
confusing effect on findings related to PVT outcomes. In addition, the present results show that female
sex, subjective sleepiness and older age together with OSA are significant predictors of poor PVT
performance. Similar findings have also been reported in other studies investigating cognitive impairment
in OSA patients and healthy individuals [9, 19, 20, 22, 35]. Moreover, in our recent studies, we reported
that a larger desaturation area is a significant predictor of objective daytime sleepiness and the most
detrimental health consequences of OSA [7, 29, 31]. Together with these findings, this study highlights the
urgent need to develop the diagnostics of OSA beyond the AHI. Diagnosis should be made more
comprehensive by characterising OSA severity with demographical information and with more detailed
parameters that are better related to the symptoms, daytime functioning and, for example, cardiovascular
comorbidities of OSA. To support the idea of utilising these new metrics in normal clinical workflow, we
have already published a plug-in for RemLogic (Natus Medical, Middleton, WI, USA) that computes these
new metrics automatically based on routine manual scoring of the sleep recording [32]. These metrics
could also be implemented in other clinical software in a similar manner.
This study has certain limitations. First, the PVT outcome variables used in this study were the standard
statistical parameters from the series of 120 reaction times. Individuals have natural differences in their
repeated reaction times, and therefore the PVT analysis could benefit from utilising the complete time
series. Nevertheless, the standard parameters used in this study enables us to compare with the existing
literature regarding the connection of OSA to PVT outcomes. Second, patients completed their PVT prior
to PSG. Individuals suffering from OSA tend to have shorter TST in PSG than normally [36], which can
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affect the odds obtained for TST. It is acknowledged that TST modulates the values of AHI and ODI to a
great extent; however, all novel parameters are also normalised by TST. Furthermore, in a recent study, it
was reported that severities of individual apnoeas, hypopnoeas and desaturations increase towards
morning [37]. Therefore, it is reasonable to assume that mean and minimum SpO2 would decrease, and
t90% as well as the mean and median depth of desaturations, would increase alongside increasing TST.
Thus, we believe that the timing of the PVT does not diminish the obtained results. Third, although the
models were adjusted with comorbidities, a complete record of patients’ medication at the time of PSG
and PVT was not available. Psychoactive and sedative medications can especially affect the reaction times
and thus PVT performance, which could affect the computed odds ratios to some extent. Fourth, this
study did not involve a control group of healthy individuals. However, the objective of this study was to
investigate which are the most significant PSG parameters associated with impaired PVT performance in
OSA patients. Therefore, patients without OSA were excluded due to the assumption that their impaired
vigilance is not caused by the same factors compared to those suffering from OSA. Fifth, no data on
patient’s habitual sleep (e.g. questionnaire, sleep diary or long-term actigraphy) were available. Short sleep
duration and chronic sleep deprivation are significantly associated with sleepiness and can, therefore, affect
neurocognitive performance [38]; thus, the lack of this information is a limitation of the present study.
In conclusion, we have shown that parameters quantifying desaturations based on their characteristic
properties have a significant association with impaired vigilance and ability to sustain attention.
Furthermore, an increase in AHI or ODI does not significantly elevate the odds of having impaired PVT
performance. These results highlight the importance of developing methods for a more detailed
assessment of OSA severity and comprehensive analysis of PSGs. This would enhance the assessment of
OSA severity and improve the estimation of risk and severity of related daytime symptoms.
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